Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.
Haematologica
; 106(7): 1867-1875, 2021 07 01.
Article
in En
| MEDLINE
| ID: mdl-32527951
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Hematopoietic Stem Cell Transplantation
/
Graft vs Host Disease
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Haematologica
Year:
2021
Document type:
Article
Affiliation country: